JPS6078962A - Production of prostaglandin d1 - Google Patents

Production of prostaglandin d1

Info

Publication number
JPS6078962A
JPS6078962A JP58187132A JP18713283A JPS6078962A JP S6078962 A JPS6078962 A JP S6078962A JP 58187132 A JP58187132 A JP 58187132A JP 18713283 A JP18713283 A JP 18713283A JP S6078962 A JPS6078962 A JP S6078962A
Authority
JP
Japan
Prior art keywords
group
bond
same
oxygen atom
prostaglandin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP58187132A
Other languages
Japanese (ja)
Other versions
JPH0210151B2 (en
Inventor
Ryoji Noyori
良治 野依
Masaaki Suzuki
正昭 鈴木
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teijin Ltd
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd filed Critical Teijin Ltd
Priority to JP58187132A priority Critical patent/JPS6078962A/en
Publication of JPS6078962A publication Critical patent/JPS6078962A/en
Publication of JPH0210151B2 publication Critical patent/JPH0210151B2/ja
Granted legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PURPOSE:To obtain a PGD1 useful as a medicine easily in high yield, by protecting the hydroxyl group at the 9-position of a specific PGF1alpha with a group capable of forming an acetal bond, and subjecting the protected PGF1alpha to the selective removal of the protecting groups, oxidation, removal of the protecting group and hydrolytic reaction. CONSTITUTION:The hydroxyl group at the 9-position in a PG(prostaglandin)F1alpha of formula I [R<11> is 1-10C alkyl or tri(1-7C) hydrocarbon silyl; R<2> and R<3> are H, substituted or unsubstituted 1-10C alkyl, etc.; R<31> is tri(1-7C) hydrocarbon silyl; R<41> is a group capable of forming an acetal bond with the oxygen atom of the hydroxyl group] is protected with the group capable of forming the acetal bond with the oxygen atom of the hydroxyl group at the 9-position thereof to give a PGF1alpha, which is then subjected to selective removal of the protecting groups, oxidation and hydrolytic reaction to afford the aimed PGD1 of formula II(R<1> is H or 1-10C alkyl; R<4> and R<5> are H, etc.). EFFECT:Separation of isomers of cubic configuration is not necessary.

Description

【発明の詳細な説明】 本発明はプロスタグランγイン1〕I(以を司) aD
lと略記)類の新規な製法に関りる。ざらに訂しくは9
4it、15位を水酸L(のM累原fど)ルタール結合
を形成りる基で保護し、11位をシリル基e保訛したP
 G D +類を誘導りる新J↓lな製法に関りる。
[Detailed description of the invention] The present invention provides prostaglan γ-in 1] I (controlling the above) aD
(abbreviated as 1). Roughly revised 9
4it, the 15th position is protected with a group that forms a hydroxyl L (M group) rutal bond, and the 11th position is protected by a silyl group e.
Involved in a new J↓l manufacturing method that induces G D + type products.

P G D r類はprinary P G JiYの
中でP G [E +、PGF+αと共に1型1) G
類に属し、生物活性ぐ白小板凝集抑制活性ではPGE、
に次いで強り13、異な生物活性をイjりる化合物であ
るが、さらにrJしい生物活性はあまり知られていない
。最近PGD+類縁体に抗血小板、抗喘息作用のある化
合物が見い出された(エリツク、ウィリアム、コリント
ンウ、特冊昭57−102877参照)。
P G Dr type 1 among the primary P G JiY [E +, PGF + α, type 1]
PGE belongs to the same group, and has biologically active platelet aggregation inhibiting activity.
It is the second most powerful compound with different biological activities, but even more biological activities are not well known. Recently, a compound having antiplatelet and antiasthmatic effects has been found in PGD+ analogs (see Erik, William, and Colin Tow, special issue 1987-102,877).

従来PGD+類の裂取にあたって+14つの方法、1な
わち (l] all−シス−8,11,14−土イ」リトリ
エン酸より“生合成によって19る方法(CJ、 Si
l+S、 Biocbemistry 、 11.22
71 (1972)参照)。
Conventionally, there are 14 methods for cleaving PGD+ species, namely, 1) a method of biosynthesis from (l) all-cis-8,11,14-lithorienoic acid (CJ, Si
l+S, Biocbemistry, 11.22
71 (1972)).

(2] P G F +αの9.11位の水lI!基の
選択的参加によって1qる方法。(G、L、Bu++d
yS、J。
(2) Method for producing 1q by selective participation of water lI! group at position 9.11 of P G F +α. (G, L, Bu++d
yS, J.

MC!d、 Cltcm 、 20. 7H(1983
>参照)。
MC! d, Cltcm, 20. 7H (1983
>Reference).

+31 11位のカルボニル基が1.3−ジヂオ)ノL
タール基で保護された化合物から得る7J払(A、T。
+31 The carbonyl group at position 11 is 1,3-didio)noL
7J payment obtained from compounds protected with tar groups (A, T.

1−1e1−1e S 、 F !L11allOdW
II 11itt、、 23. 5(31(1982)
参照)。
1-1e1-1e S, F! L11allOdW
II 11itt,, 23. 5 (31 (1982)
reference).

(4) 9.11.1!i位の異なるシリル赫で保りさ
れたP G F +α誘尋体から誘導°す°る方法Lj
l−,W。
(4) 9.11.1! A method of deriving Lj from P G F + α derivatives maintained by different cylindrical molecules at position i
l-, W.

トtart S 、J、 Chem、Com1,156
 (197j) 参 照 )が知られている。
Tart S, J, Chem, Com1,156
(197j)) is known.

しかるに、これらの方法にJ3いり(1)の生合成によ
ってIl、Iる方法では原料である多価不飽和脂肪酸が
人手困難であるばかりでなく、生合成では1:已にP 
G E + 、 P G F ’+αが副生し、P G
 l) +の裂取にはこれらと分離しなければならす゛
1−業的な仏味で難点が多い。(2)の化学合成υ、で
は9.11位の2つの遊離の水酸是の内、11位のみを
選択的に酸化リ−る所に反応の微妙な制御をしなGノれ
ばならず、しかも収率も低く、■葉内に必ずしも渦層の
Ii<ものではない。(3)の方法では11位のカルボ
ニルを1.3−ジチAアレタールで保護しIこ中聞体を
利用するため、12位の立体構造はP G骨格合成1)
!1には制御用)1′、なく、生成物は非人然ハリの異
性体とのi;〜合物となり、これらの分離のJ急に難点
がある。(4)の7J rLでは9位、11位を15位
のシリル保護基とは異なる同じ保護基ぐ保護し、11位
のみを9位と区別し−C選択的に脱保ムρどは異なる同
じ保護基ぐ保護し、11位のみを9位と区別し一0TU
択的に11)2保、15基1−るという方法であり、微
妙な反応制御を必裏どし、しかも11位の保護基変換を
2回もtjなうという工程上の複雑さがあり、工業的に
満足リベき方法で口えない。
However, in these methods, the polyunsaturated fatty acids that are the raw materials are not only difficult to handle manually, but also the biosynthesis involves the biosynthesis of 1:P.
G E + , P G F '+α are produced as by-products, and P G
1) There are many difficulties in separating + from these 1- karma-like Buddha tastes. In chemical synthesis υ of (2), it is necessary to delicately control the reaction to selectively oxidize only the 11th position of the two free hydroxyl acids at the 9.11th position. Moreover, the yield is low, and there is not necessarily a swirl layer within the leaves. In method (3), the carbonyl at position 11 is protected with 1,3-dithia aretal and the I mesidium is used, so the steric structure at position 12 is created by PG skeleton synthesis 1)
! 1 does not have 1' for control, and the product is a compound with an unnatural isomer, and there are difficulties in separating these. In 7J rL of (4), positions 9 and 11 are protected with the same protecting group different from the silyl protecting group at position 15, only position 11 is distinguished from position 9, and -C selective deprotection ρ etc. are different. Protected with the same protecting group, distinguishing only the 11th position from the 9th position, 10TU
Alternatively, 11) is a method in which 2 groups and 15 groups are 1-, which requires delicate reaction control and is complicated in the process of converting the protecting group at position 11 twice. , in an industrially satisfying manner.

本発明省らはかかる点に着目し、ブト1スタグランデイ
ンD1類の有利な化学合成法を兄いだJべく鋭危(il
+究しlこ結果、l)G骨格合成U+冒こ用いられる水
酸基保護基を巧みに利用し、9位、15位と水酸基の酸
素原子どアレタール結合を形成する基で保護6.11位
をシリル基で保護したP G F + α類から、11
位のみを所定の官能基変換りることににすP G D 
+類を得ることに成功し、本発明に到達したものである
The Ministry of the Invention and others have focused on this point and have developed an advantageous chemical synthesis method for buto-1 staglandin D1.
As a result of the research, l) G-skeleton synthesis U + Invention We skillfully utilized the hydroxyl protecting groups used to protect the 6 and 11 positions with a group that forms an alletal bond between the 9th and 15th positions and the oxygen atom of the hydroxyl group. From PGF + α species protected with silyl group, 11
We decided to convert only the position with a predetermined functional group.
We succeeded in obtaining the + class and arrived at the present invention.

すなわち 下記式(1) 式中R11はC1〜Cooのアルキル基又は1〜す(C
I−07)炭化水素シリル基を現わし、R2、R3は同
一もしくは異なり水素原子、置換もしくは非直換の01
〜C10のアルキル基又は置換もしくは非置換の5)〜
6員のシクロアルキル基を表わし、1(31はI・す(
(、+〜Cy )炭化水ルシリル基を表わし、「(41
は水酸基の酸素原子と共にアゼタール結合を形成りるλ
(を表わり。
That is, in the following formula (1), R11 is a C1-Coo alkyl group or 1-Coo (C
I-07) represents a hydrocarbon silyl group, R2 and R3 are the same or different hydrogen atoms, substituted or non-directly substituted 01
~C10 alkyl group or substituted or unsubstituted 5)~
Represents a 6-membered cycloalkyl group, 1 (31 is I.S(
(,+~Cy) represents a hydrocarbon lucilyl group, and "(41
is λ that forms an azetal bond with the oxygen atom of the hydroxyl group.
(Represents.

で表わされるブ[1スタグランディン1−1 αP:i
olの9位の水M基を水l12基の酸素1京子と共にj
ILタール結合を 形成りる阜で保護し、下記式(2) 式中R” 、 R” 、 Iで3,1(引は上記に同じ
で、1【51は1<41と同−又は異なり水酸150)
酸素15:ミ子と共にアレリール結合を形成りる基を表
ねり。
bu [1 staglandin 1-1 αP:i
The water M group at the 9th position of ol is j
It is protected by a method that forms an IL-tar bond, and the following formula (2) is formed, in which R", R", and I are 3,1 (the subtraction is the same as above, and 1<51 is the same as or different from 1<41). Hydroxic acid 150)
Oxygen 15: Represents a group that forms an allelyl bond with Miko.

で表わされるプロスタグランティン上1αフエ毒を1−
ノ、これを選択的脱保護、次いで酸化しIこ後必要に応
じて脱保護及び/又は加水分解反応にイ4りことを1)
徴どり−る下記式(3) 式中R2、R3は上記定義に同じ、R1は水素原子、C
1〜Cooのアルキル基又は1−リ(C+〜C7)炭化
水素シリル基を表わし、R4、R5は同一もしくは異な
り水素原子又は水酸基の酸素原子と共にアゼタール結合
を形成する基を表わり。
Prostaglantin supra1α fue toxin expressed as 1-
1) This is selectively deprotected, then oxidized, and then subjected to deprotection and/or hydrolysis reaction as necessary.
The following formula (3) in which R2 and R3 are the same as defined above, R1 is a hydrogen atom, and C
It represents an alkyl group of 1 to Coo or a 1-li(C+ to C7) hydrocarbon silyl group, and R4 and R5 are the same or different and represent a group that forms an azetal bond with a hydrogen atom or an oxygen atom of a hydroxyl group.

で表わされるプロスタブランディンD+類の製法である
This is a method for producing prostablandin D+ expressed by:

本発明方法において用いられる上記式(1)で表わされ
るプロスタブランディンF+ α類はまえ捉系されてい
る方法(特願昭b7−163082参照)によりワーヒ
ドロキシPGEまたは1:類(特開昭58−99462
@参照)から容易にかつ高収串で調r!l!リ−ること
が出来る。
The prostablandin F+ α group represented by the above formula (1) used in the method of the present invention is obtained by a previously captured method (see Japanese Patent Application No. 7-163082). -99462
(see @) can be easily and easily cooked with a skewer with high yield! l! It is possible to read.

上記式(1)において、RI+は、C1〜CIOのアル
キル基又はl・す(CI”−Cy)炭化水素−シリル基
を表ねり。01〜CIOのアル4ル基としくは、例えば
メチル、’ :t アル、 11−ブメピル、 1so
−ゾ[1ビル、11−ブチル、 5ec−ブチル、 L
ert−ブチル、11−ペンデル、ローヘキシル、ロー
へプヂル、++−4タチル。
In the above formula (1), RI+ represents an alkyl group of C1 to CIO or a hydrocarbon-silyl group of 01 to CIO. Examples of the alkyl group of 01 to CIO include methyl, ' :t al, 11-bumepyr, 1so
-zo[1-biru, 11-butyl, 5ec-butyl, L
ert-butyl, 11-pendel, rhohexyl, rhohepdyl, ++-4 tatyl.

0−ノニル、++−qシル等の直鎖状又は分岐状のもの
を挙げることができる。なかでしメチル阜、■チル基が
好ましい。トす(C+〜Cy>炭化水系−シリル基どし
ては、例えばトリメデルシリル、1〜リエブルシリル、
し−ブブルジメチルシリル基の如く1〜す(C+〜C4
)アルキルシリルもt;しゾf−ルジフ1ニルシリル基
の如くシフ上ニル(C+〜C4)アル4ニルシリル基又
は1〜リベンジルシリル基等を挙げることができる。
Linear or branched ones such as 0-nonyl and ++-q-syl can be mentioned. Nakadeshi methyl group and (2) thyl group are preferred. Examples of the (C+~Cy>hydrocarbon-silyl group) include trimedelsilyl, 1-liablesilyl,
1-(C+-C4
)Alkylsilyl also includes a Schiffonyl(C+-C4)al4nylsilyl group or a 1-ribenzylsilyl group, such as a diphenolsilyl group.

!<2.R3は同一もしくは異41す、水系原子または
置Ji bL、、 < tよ非買換り01〜(/ 10
の)′ルー1−ル基としては例えば、メチル、1−デル
11−ノ゛11ピル。
! <2. R3 is the same or different, water-based atom or substituted JibL,, < t, non-replaceable 01~(/
Examples of the 1-l group include methyl, 1-del11-nol-11-pyl.

730−プロピル、l)−ブチル、トペンブル、旧l\
−1−シル、2−メチル−1−ヘキシル、2−メブルー
2−ヘキシル、 11−ヘブチル、 n−Aクブル等の
i0領状又は分岐状のものが挙げられる。非置換の5・
−6員のシクロアルキル基としては、シクロペンチル塁
、シクロヘキシル基などが挙げられる。かかる非置換の
01〜Cooのアルキル基、非置換の5〜G員のシクロ
アルキル基の置換基としては例えば、メチル、エチル、
フ1ノキシ、1〜リフルA日メチル、トリフルオロメチ
ルフェノキシ基などが好ましく挙げられる。特にR2と
し−Cは、メチル。
730-propyl, l)-butyl, topemble, former l\
-1-Syl, 2-methyl-1-hexyl, 2-mebru-2-hexyl, 11-hebutyl, n-A cube, and other iO-regular or branched compounds are mentioned. unsubstituted 5.
Examples of the -6-membered cycloalkyl group include a cyclopentyl group and a cyclohexyl group. Substituents for such unsubstituted 01-Coo alkyl groups and unsubstituted 5-G membered cycloalkyl groups include, for example, methyl, ethyl,
Preferred examples include phenoxy, methyl, trifluoromethylphenoxy, and the like. In particular, R2 and -C are methyl.

フェノキシ曇もしくは1−リフルオロメチルフェノキシ
基で置換されていてもよいメチル、11−ペンチル、1
1−ヘキシル、2−メチル−1−ヘキシル、シクロペン
チル基又はシクロへキシルJ、4が好ましく、かてもn
−ペンチル、11−ヘキシル、2−メチル−1−ヘキシ
ル、シクロペンチル、シクロヘキシルが好ましい。R3
とし°Cは水素原子又はメチル基が好ましく、特に水;
h原子が好ましい。
Methyl, 11-pentyl, 1, optionally substituted with phenoxy or 1-lifluoromethylphenoxy group
1-hexyl, 2-methyl-1-hexyl, cyclopentyl group or cyclohexyl J,4 is preferred, even n
-Pentyl, 11-hexyl, 2-methyl-1-hexyl, cyclopentyl and cyclohexyl are preferred. R3
and °C is preferably a hydrogen atom or a methyl group, especially water;
An h atom is preferred.

R31,1,す(IC+へ・C7)炭化水素−シリル基
を表わし、なかぐも1−チブチルジメチルシリルM。
R31, 1, (to IC+/C7) represents a hydrocarbon-silyl group, and is also 1-tibutyldimethylsilyl M.

トリエチルシリル基が好ましい。R”は水酸基の酸素原
子と共にアセタール結合を形成する基を泡ねし、例えば
メ1〜キシメチル、1−エト4ニジ1チル、2−メl〜
キシー2−ブL1ヒル、2−土1ヘキシー2プUビル、
く2−メ1〜1シ土1・4シ〉メチル。
Triethylsilyl group is preferred. R'' represents a group that forms an acetal bond with the oxygen atom of the hydroxyl group, such as methyl-oxymethyl, 1-eth4-di-1-methyl, 2-methyl-
Kishi 2-B L1 Hill, 2-Sat 1 Hexie 2P U Building,
Methyl.

ベンジル71Aジメチル、2−テトうじ1ζ11ビ−ノ
ールネ2−j−1〜うじド1−1−ノンニル、6.6−
ジメチル−3−′A−1ニリ −2−A4ニソ −じシ
フ1」(3,1゜O)へ4ス−4−イル基などが)i月
yられる。1<41はなかでも、じドロピラニル基、1
−I+−=1−シ土デル基、2−メ1〜4シー2〜プロ
ピル基がθfましい。
Benzyl 71A dimethyl, 2-tetouji1ζ11binolne2-j-1~ugido1-1-nonyl, 6.6-
A 4-4-yl group, etc., is added to dimethyl-3-'A-1ni-2-A4-di-Schiff-1' (3,1°O). 1<41, inter alia, didropyranyl group, 1
-I+-=1-side del group, 2-me1-4cy2-propyl group is preferred.

本発明/J払にJ3りる前記式(1)〜(3)0表わ凸
れるPG類はその、8位、9位、11位、12位、11
1位。
The PGs that appear in the above formulas (1) to (3) 0 for the present invention/J payment are 8th, 9th, 11th, 12th, and 11th.
1st place.

に不斉炭A BI子をイJす゛るため、各種の立体異性
体が存在り゛るが、本発明方法にお4Jるl−) G類
tよこれらの鏡像体、光学異性体及びそれらの−ξれi
5.の混合物を包含り゛る。
Various stereoisomers exist in order to contain the asymmetric carbon ABI molecules, but in the method of the present invention, these enantiomers, optical isomers, and their -ξrei
5. It includes a mixture of

本発明方法は上記式(1)のjロスタクランノ゛インF
1α類の9位水酸基を水酸基の酸メ1;ミ丁ど」(にア
レタール結合を形成り°る基で保護りることがら開始さ
れる。保護剤としては2−3−ジヒド11ピシン、−[
プルビニル1−フル、アl〜ンジメ1ルアセタル2等が
用いられる。これら保護剤は原料のプロスタグランディ
ンF!α類に対して1〜20当量、好ましくは1〜5当
量用られる。反応助剤としてピリジンバラトルエンスル
ボン5t=(ppTS)、カンフ7スルホン酸等を原料
プロスタグランデスンF+α類に対して0.1〜100
重伝%りfましくは1〜30重量%用いるのが良い。反
応は無水のエーテル類8例えばエチルニーデル、テトラ
ヒドメフラン、ジオ7−ナン等はまt=は無水ハ目グン
化炭化水素、たとゆばメチレジクロリドクロLTIホル
ム、ジクロロエタン等中で行なうことも出来る。反応温
度は一10℃〜60℃りTましくはO℃〜30℃で進h
 、反応の終点は薄層りUマドグラフィー等で原料の消
失を観測して確LE ’Iる。かくして反応液は通11
−の方法により後処理し、生成物どして上記式(2)で
表わされる11位ガシリル基で保護され、9位、15位
が水酸基の酸素ハ;ミ子と共にアレタール結合を形成り
°る基で保護されたPGF+ α類が得られる。次にこ
の化合物の11位のシリル化IIを選択的に脱保護する
。これはテトラ−11−プチルアンモニウムフルオリド
、フッ化水素−ヒリジン。
The method of the present invention is based on the above equation (1).
The process starts by protecting the hydroxyl group at the 9-position of the 1α group with a group that forms an aretal bond on the hydroxyl group. As a protecting agent, 2-3-dihydro-11-picine, - [
Pluvinyl 1-fur, 1-alvinyl 1-fluorene acetal 2, etc. are used. These protective agents are made from prostaglandin F! It is used in an amount of 1 to 20 equivalents, preferably 1 to 5 equivalents, relative to the α group. As reaction aids, pyridine balatoluene sulfone 5t=(ppTS), camphu 7 sulfonic acid, etc. are used at a concentration of 0.1 to 100 relative to the raw material prostaglandesone F+α.
It is preferable to use 1 to 30% by weight. The reaction can also be carried out in anhydrous ethers such as ethyl needle, tetrahydromefuran, di-7-nan, etc., or anhydrous chlorinated hydrocarbons, such as methyl dichloride, LTI form, dichloroethane, and the like. The reaction temperature is -10°C to 60°C or more preferably 0°C to 30°C.
The end point of the reaction can be determined by observing the disappearance of the raw materials using thin-layer magnetography or the like. Thus, the reaction solution was
- The product is protected by the 11th-position gasylyl group represented by the above formula (2), and the 9th and 15th positions form an aretal bond with the hydroxyl group oxygen group. PGF+α group-protected group is obtained. Next, silylated II at position 11 of this compound is selectively deprotected. This is tetra-11-butylammonium fluoride, hydrogen fluoride-hyridine.

特に妊ましくは、デトラー11−ブ1ル)′ンしニウム
ノルオリドを用いることにより通7:iのZJ法により
)100R4′ (式中R” 、R2、R3,R” 、R”は上記に同じ
。)で表わされる9位、15位が保護されjこ1)GF
 Iα類を容易にるごとが出来る。この生成物はそれ自
体公知の方法([,1三 、N il+iqawa 3
 1)tostaglandi+to 9 、 109
 (1975) 参照)により、例えばJO11eS試
集、り1」ルクUム酸ビリジーウ11等のクロム酸系酸
化剤により、11位の水酸基を酸化し、必要に応じCR
” 、R”の保J7.tを除去しても良い。除去にあた
っては例えば酊醒−水−テトl」ヒトフラン混合物(3
:1:1〜3 : 2 : 2 )中で生成物を室温で
処i!1!することによって達成される(E、 J、 
Corcy ら 、 J 、 A mar、 CIoa
m。
In particular, by using Detler's 11-butylnylnorolide, 100R4' (wherein R'', R2, R3, R'', R'' are the same as above). The 9th and 15th positions represented by ) are protected.1) GF
I can easily read class Iα. This product can be prepared by a method known per se ([,13,Nil+iqawa3
1) tostagrandi+to 9, 109
(1975)), for example, the hydroxyl group at position 11 is oxidized with a chromic acid-based oxidizing agent such as rucumic acid pyridium 11, and CR is added as necessary.
" , R" protection J7. t may be removed. For the removal, for example, a mixture of intoxication-water-tetyl-hydrofuran (3
:1:1 to 3:2:2) at room temperature. 1! (E, J,
Corcy et al., J., Amar, CIoa
m.

Soc、、24,6190 (1972)を参照)。Soc, 24, 6190 (1972)).

また必要に応じて、1位のエステルI(R’l)を加水
分解してもよい。かかる加水分解は、例えばF型1) 
Gはアルカリ性水溶液、F型1) GはリバーU、Iス
テラ−U等の加水分解酵素を用い(1jなうことができ
る。
Furthermore, if necessary, the ester I (R'l) at the 1st position may be hydrolyzed. Such hydrolysis, for example F type 1)
G can be an alkaline aqueous solution, F type 1).

かくして]」的とり−る上記式(3)で表わされるl−
’GD1類を容易に、畠収率で得ることが出来る。
Thus, l- expressed by the above formula (3)
'GD1 class can be easily obtained at a high yield.

本発明方法の特徴は次にある。′TJなわら出発Lξ料
(1)おいて生じた9位、11位、15位の水酸基の保
護状態の相違をそのまよ利用し−C,従来法にあるよう
な保護基変換をすることなく上記式(4)で示される中
間体を誘尋し、これをP G D l類に尋びくという
方法である。この方法は従来法に比較してはるかにイ」
刊に、しかし立体4M mの異性体分離をすることなく
 P G D r類を提供することが出来る方法どいえ
る。以下本発明方法を実施例ににり更に詳細に説明する
The characteristics of the method of the present invention are as follows. 'TJ, by making full use of the differences in the protection states of the hydroxyl groups at positions 9, 11, and 15 that occurred in the starting Lξ material (1), -C, and converting the protecting groups as in the conventional method. This is a method in which the intermediate represented by the above formula (4) is introduced instead, and this is asked of the PGD1 group. This method is much better than the conventional method.
However, there is a method that can provide P G Drs without stereoisomer separation of 4M m. The method of the present invention will be explained in more detail below with reference to Examples.

実施例1゜ 1 (103#I!J)を10meのナスフラスコにど
りi mQのdl゛yCtL CUzを加えた。水浴で
冷却し、33mgの2.3−ジヒI・ロピランを加え、
つづいて14mgのl) I) T Sを加え、0℃テ
10分間、:(O℃’e j′)If、’j間撹拌した
。反応液を塩化メチレン5 mQで希釈したのら、飽和
食塩を抽出した。(2X 10++ie )41機層を
含わゼ、無水MilWす1〜リウム−(゛乾燥した。減
圧濃縮後、シリカグルー力ラうクロントグラノイーに供
し、(M 0rCk礼製シリ力ゲル12g;1llxヂ
:ヘキ(ノン−1: io) 、生成物として一?−を
 1111](収率94%)(!1k。
Example 1゜1 (103#I!J) was placed in a 10me eggplant flask and imQ dlyCtL CUz was added. Cool in a water bath, add 33 mg of 2,3-dihi I-ropyran,
Subsequently, 14 mg of l)I)TS was added and stirred at 0°C for 10 minutes. After diluting the reaction solution with 5 mQ of methylene chloride, saturated sodium chloride was extracted. (2X 10++ie) containing 41 gels, anhydrous MilW 1~lium (2) was dried. After concentration under reduced pressure, it was applied to a silica glue gel (12 g of silica gel made by M0rCk); 1111] (yield 94%) (!1k.

IR(CI−IC麦3 ) : 1730cm−111
NMR(CDCJla 、90〜I 11 Z 、1l
iln+ ) δ :0.007(S、 6. Si’
 Cl−13X 2 ) 、0.7− 1.0(12,
Si C(CH3) 3 and Cト13 ) 、 
1.1−2.5(m、3G、CH2X17) 、4.5
− 4.8(m。
IR (CI-IC Mugi 3): 1730cm-111
NMR (CDCJla, 90~I11Z, 1l
iln+) δ:0.007(S, 6.Si'
Cl-13X 2 ), 0.7-1.0 (12,
Si C(CH3) 3 and C13),
1.1-2.5 (m, 3G, CH2X17), 4.5
- 4.8 (m.

2.0CI−10X2)、5.40 (Il、2.vi
++y1 >TLC: I<f : 0.54 (Et
 OAc −1+exa+、c=1 :4) 旋光度:[α] = 15.9’ (G 003G5゜
MeOl−1> 実施例2 工(26ffljF )を5dの試験管にとり、0.1
−の乾燥Cl−12cJ12を加えた。水浴で冷却し、
4.7■の2,3−ジヒドロビランを加え、・つづいU
 P P TS O,2ayを加え、0℃テ10分間室
m (2Q’C) T’ 1時間、30℃で1時間撹拌
後、2゜3−ジヒドロビラン4.7m+5y P P 
−1−30,2mgを加え、30’CF2時間撹拌した
。さらに2.3−ジヒドロビラン4.7mg 、 l)
t〕T S q、2mgを加え、1時間撹拌した。反応
液を塩化メチレン5dで希釈したのL)、飽和良1n水
10dを加え、よく振とうした。右は層、水層を分画後
、ナトリウムで乾燥しIこ。減圧jlニ縮後、シリカゲ
ルカラムクロマトグラフィーに供しく tvl erc
kネ1シリカゲル1,77 :酢」−ブー:へキリン−
1:10)、−1成物先を29〜(収率97%)着た。
2.0CI-10X2), 5.40 (Il, 2.vi
++y1>TLC: I<f: 0.54 (Et
OAc-1+exa+, c=1:4) Optical rotation: [α] = 15.9'(G003G5゜MeOl-1> Example 2 0.1
- of dry Cl-12cJ12 was added. Cool in a water bath;
4. Add 7■ of 2,3-dihydrobilane, and continue with U.
P
-1-30.2 mg was added and stirred for 2 hours at 30'CF. Additionally, 4.7 mg of 2,3-dihydrobyran, l)
t]T Sq, 2 mg was added, and the mixture was stirred for 1 hour. The reaction solution was diluted with 5 d of methylene chloride, 10 d of saturated 1N water was added, and the mixture was thoroughly shaken. The layer on the right is the layer. After fractionating the aqueous layer, dry it with sodium. After condensation under reduced pressure, it was subjected to silica gel column chromatography.
Kne 1 Silica gel 1,77: Vinegar - Boo: Hekirin -
1:10), -1 product was obtained in 29~ (yield 97%).

スペクトルデータは実施例1に同じであった。The spectral data were the same as in Example 1.

10m1!(1)す7.う75ス’−11に:2を10
3.5#lj/とり−1−I11ン1eで溶解し1この
ちに、+1−[3u a NF (IM/ T I−I
 F ) 1.58 mlを加え、室温(23℃> (
・it vエチル5Idを加えてよく振りよ「、41機
層と水層を分けた。水層を酢酸エチルで抽出した(5d
×2)、右t!1層を合わせ、無水硫酸プトリウムC乾
燥した。減;王濃縮後、シリカゲルカラムカラムクロマ
1−グラフィーに供しく M OI’Ckシリカゲル1
07;酢エヂル:11−ヘキサン=1 :4)、生成物
として−5−をを71.7mg(収率84%)1−1k
10m1! (1) 7. 75s'-11: 2 to 10
3.5#lj/Tori-1-I11 Dissolve in 1e, 1 After that, +1-[3u a NF (IM/ T I-I
Add 1.58 ml of F) and bring to room temperature (23℃> (
・Add ethyl 5Id and shake well. 41 Separate the organic layer and aqueous layer. Extract the aqueous layer with ethyl acetate (5d
×2), right t! One layer was combined and dried with anhydrous Putrium C sulfate. After concentration, it was subjected to silica gel column column chroma 1-graphy. M OI'Ck silica gel 1
07; Acetyl acetate: 11-hexane = 1:4), 71.7 mg (yield 84%) of -5- as a product 1-1k
.

I R(C1−I C113) : 3620−328
0.1730cm−’トIN M R(CDCM 3 
、9(IMI−12、1)l)m ) δ :0.88
 (t、 3. 4.51−12 、 Cl−13> 
、1.1−2.5(m、37. CH2X17. cl
−1x 2. alld 0tl)、3.3−4.5(
+i、10,0CI−h 、Cl−10X3゜alld
 CH20X2) 、4.5−4.8(m、 2.0C
I−10x2>、 5.45 (劇1. 2 、Vil
l yl )薄層クロマトグラフィー : Rr : 0.り4 (L L OACIIC!X
allO=1:4) 旋光度:[α]−[α] =+0.65゜(CO,58
8,Me Ol−1) 実施例4 5mの試験管に6を29.24とり−1−l−l F 
O,5meで溶解しlcのら、n−Bu a’ N F
 (I tvl/−I用1l−)0.45 mRを1」
11え、空温り21℃、 Ptvl 4 : 110)
で4111間撹拌した。Tl1F2dで希釈ののら飽和
良」n水2I+認を加え、よく振りまぎた。rll酸■
チル5rnQを加えてよく振りよ「、右はUと水層を分
()た。
IR (C1-I C113): 3620-328
0.1730cm-'TOINMR(CDCM3
, 9(IMI-12, 1)l)m) δ: 0.88
(t, 3. 4.51-12, Cl-13>
, 1.1-2.5 (m, 37.CH2X17.cl
-1x 2. alld 0tl), 3.3-4.5(
+i, 10,0CI-h, Cl-10X3゜alld
CH20X2), 4.5-4.8(m, 2.0C
I-10x2>, 5.45 (Drama 1.2, Vil
yl) Thin layer chromatography: Rr: 0. ri4 (L L OACIIC!X
allO=1:4) Optical rotation: [α] - [α] = +0.65° (CO, 58
8, Me Ol-1) Example 4 29.24 of 6 was placed in a 5 m test tube and -1-l-l F
Dissolved in O,5me, then n-Bu a' NF
(I tvl/-1l- for I) 0.45 mR 1''
11, air temperature 21℃, Ptvl 4: 110)
The mixture was stirred for 4111 minutes. After diluting with Tl1F2d, saturated water was added and the mixture was shaken well. rll acid■
Add Chill 5rnQ and shake well. On the right, separate the U and water layers.

水層をi1酸エヂルで抽出した( り mQ X 2 
)。濃縮後シリカゲルカラムク1」7トグラフイーに供
しくメルクシリカゲル1.;Iび、01酸■デル:11
−ヘキリンー’l : 2 ) 、生成物7を20mg
 (収率83%)1′7だ。
The aqueous layer was extracted with yl acid (
). After concentration, Merck silica gel 1.7 was subjected to silica gel column 1. ; Ibi, 01 acid ■ Del: 11
-Hekylin'l: 2), 20 mg of product 7
(yield 83%) 1'7.

このものの性質はり;施例3の、b−どIi+I I;
Cあった。
The properties of this item are: Example 3, b-do Ii+II;
There was C.

実施例5 Th?0 10m!lのナスフラスコに5を[i5.1#I9とり
、アt? l−ン3dで用意しIC。アルゴン気流下、
−30℃でジョーンズ反応剤55.4m(lをマイクロ
シリンジで滴下した。−30℃で50分撹拌後、飽和炭
酸水素す1−リウム水溶液3mを加え、檄しく境11′
シた。水層が緑色に変化したのち、m酸エチル10威、
飽和炭酸水系〕−トリウム水溶液10mQを加え、ゐし
く振とうした。右機層を合わせ、7!lj水11il 
Mノー1−リウムC乾燥した。減圧濃縮後、シリカゲル
カラムクロマ1へグラフィーに供しく M erckシ
リカゲル7g;酢土チ:へギサン−1:2)、生成物と
して邊−を64.IIyJ(収率99%)得た。
Example 5 Th? 0 10m! Take 5.1 #I9 in a l eggplant flask and at? Prepared IC with l-on 3d. Under argon flow,
At -30°C, 55.4 m (l) of Jones reagent was added dropwise using a microsyringe. After stirring at -30°C for 50 minutes, 3 m of a saturated aqueous 1-lium bicarbonate solution was added, and
Shita. After the aqueous layer turns green, 10% ethyl m-acid,
10 mQ of a saturated carbonated aqueous]-thorium aqueous solution was added, and the mixture was shaken thoroughly. Combine the right machine layer, 7! lj water 11il
Mnorium C was dried. After concentration under reduced pressure, it was subjected to graphy on a silica gel column Chroma 1 (7 g of Merck silica gel; acetic acid: hegisan (1:2)), and 64. IIyJ (yield 99%) was obtained.

IR(C1−IC,Q3) : 173!Icm−’ 
:1−INMR<CDCILs 、 90Ml−1z 
、 DI]III )δ:0.88 (t、 a、 J
= (1,0+−12、CH3) 、1.1− 2.’
l(m、3G、CI−+2 x17 a++d Cll
X2)。
IR(C1-IC,Q3): 173! Icm-'
:1-INMR<CDCILs, 90Ml-1z
, DI] III) δ: 0.88 (t, a, J
= (1,0+-12,CH3), 1.1-2. '
l(m, 3G, CI-+2 x17 a++d Cll
X2).

3.3− 4.8(m、N、0C1h 、Cl−10x
2.CI+2 0X 2 、acid ocl−fax
 2 ) 、5.3− 5.6(m、2 、’ vin
yl ) −rLC: Rf : 0.33 ([t OAC−1
+cxa++a=i:2) 旋光度:[α]=0.G3° (CO,7!i7!i 
3.3-4.8 (m, N, 0C1h, Cl-10x
2. CI+2 0X 2, acid ocl-fax
2), 5.3-5.6(m, 2,' vin
yl ) -rLC: Rf : 0.33 ([t OAC-1
+cxa++a=i:2) Optical rotation: [α]=0. G3° (CO,7!i7!i
.

1yleOH> 5 mQの試験管に7を11.[infとり、7’ t
 I−ン0,6−で溶解した。)アルゴン気流下、−3
0℃でジョーンズ反応剤をシリンジで滴下した。−30
℃で4()の撹拝復、酢酸]エチル1dで希釈し、飽和
炭酸水素すトリウム水溶液′l mQを加え、激しく撹
拌した。
1yleOH > 11.7 in a 5 mQ test tube. [inf, 7' t
It was dissolved in I-ne 0,6-. ) Under argon flow, -3
Jones reagent was added dropwise with a syringe at 0°C. -30
The mixture was stirred at 4° C., diluted with 1 d of ethyl acetate, added with a saturated aqueous solution of sodium bicarbonate, and stirred vigorously.

水層が緑色に変化したのち、さらに酢酸エチル10威飽
和炭酸水素すトリウム10mQを加え激しく撹拌しl〔
。イl+ [1層、水層を分離後、水層を酢酸土デルで
抽出した(2X10d)有機層を合わせ、無水硫酸ノト
リウムで乾燥した。減圧淵11?i F2、シリカゲル
カラムクロマトグラフィーに供しく Mcrck O,
9シ;耐エヂ:l\キ→ノン−1:2)、生成物としく
υ−を11mg(収率95%)(すだ。このものの性質
は実施例5に同じであった。
After the aqueous layer turns green, add 10 mQ of saturated ethyl acetate and 10 mQ of saturated sodium bicarbonate, and stir vigorously.
. After separating the aqueous layer, the aqueous layer was extracted with acetic acid (2×10 d). The organic layers were combined and dried over anhydrous notrium sulfate. Decompression deep 11? i F2, subjected to silica gel column chromatography McCrck O,
9; Edge resistance: l\ki→non-1:2); 11 mg (yield 95%) of the product υ-; the properties of this product were the same as in Example 5.

実施例7 TI9ol−1c+ 8 (55,2me )を7dのCLl 3COOl−
l ’ l−120−THF(3:1:1)に溶かし、
45℃で10.711’i間撹拌した。ロータリーエバ
ポレーターで濃縮し、トルエンで共沸したく3回)。濃
縮液を直接シリノJグルカラムクロマグラフィー(M 
erckシリカゲル5g;酢エヂ:へ:1−4ノンー1
:1)に供し、生成物としてP G D +メチルニス
アル川を28.78+y(収率76%)111k。
Example 7 TI9ol-1c+ 8 (55,2me) was converted into 7d CLl 3COOl-
l' l-120-dissolved in THF (3:1:1),
Stirred at 45°C for 10.711'i. Concentrate on a rotary evaporator and azeotrope with toluene (3 times). The concentrated solution was directly subjected to Silino J Glucolumn chromatography (M
erck silica gel 5g; vinegar edge: to: 1-4 non-1
:1), and the product was P GD + methyl Nissal 28.78+y (yield 76%) 111k.

l R(C1−1cJ13 ) : 3720−324
0. N30cm”’11NMR(CDCす3.90M
IIz 、 111111 )δ:0.89 (t、 
3. J = 6.4Hz 、 CH3) 、1.1−
 2.1 (m、21.CH2x9.cl−1,and
 01lx2> 、2.32 (I、 2.’J= 7
.0LIZ 、 Cl−12C00G) 、2.44 
(d、 2. J−2,6112、C112C=O) 
、2.79 (dd、 1 、 J=11.Gtlz 
lR(C1-1cJ13): 3720-324
0. N30cm"'11NMR (CDCS3.90M
IIz, 111111) δ: 0.89 (t,
3. J = 6.4Hz, CH3), 1.1-
2.1 (m, 21.CH2x9.cl-1, and
01lx2> , 2.32 (I, 2.'J= 7
.. 0LIZ, Cl-12C00G), 2.44
(d, 2. J-2,6112, C112C=O)
, 2.79 (dd, 1, J=11.Gtlz
.

7.0llz 、 ClIC=0) 、3.67 (s
、 3. QCl−13) 、4.08 <ill’、
Q、 1..1− C1,211Z 、 (〕110)
 、4.!71 (m、 1 、 Cll0) 、!+
、37’(dd。
7.0llz, ClIC=0), 3.67 (s
, 3. QCl-13), 4.08 <ill',
Q.1. .. 1- C1,211Z, (]110)
,4. ! 71 (m, 1, Cll0),! +
, 37' (dd.

1 、 J=1!i、4. 7,0112 、 Vil
lV i ) 、5.C33(dd、 1 、 J−1
!+、4. 6.211z ) ;CNMII(CDC
す3.90M Hz、111111 )δ14.1.2
2,7.24.8.25.2.2G、9.28.0.2
9.0゜29.5.31.8.34.0.3t3.!J
、 47,9.48.2.51.!i。
1, J=1! i, 4. 7,0112, Vil
lV i ), 5. C33 (dd, 1, J-1
! +, 4. 6.211z) ;CNMII(CDC
3.90MHz, 111111 ) δ14.1.2
2, 7.24.8.25.2.2G, 9.28.0.2
9.0°29.5.31.8.34.0.3t3. ! J
, 47, 9.48.2.51. ! i.

!i4.9.68.1.72.11. 12G、6. 
138,8. 174.4゜217.3 TLC’: Rf : 0.64 (Et OAc −
cyclol+cxa++c −−1−l−I F =
 G : 3 : 1 )旋光痕:[αコ −t−23
,8,” (CLl、355゜Meal) 実施例8 9 3.3m9を0.5m(7)AC011−1−12
0−−r LIF(3:1:1)に溶かし、45℃”C
: 711.’+間撹J’l′l。
! i4.9.68.1.72.11. 12G, 6.
138,8. 174.4°217.3 TLC': Rf: 0.64 (EtOAc-
cyclol+cxa++c −−1−l−I F =
G: 3: 1) Optical rotation trace: [αco-t-23
,8,” (CLl, 355°Meal) Example 8 9 3.3m9 to 0.5m (7) AC011-1-12
0--r Dissolved in LIF (3:1:1) and heated at 45℃"C
: 711. '+ stirring J'l'l.

た。真空ポンプで溶媒し、トルエンでバ?ll (3回
)で溶媒を溜去し、シリカゲルカシムクL171〜(M
e r Ckシリカゲル0.69 :酢エチ:ヘキサン
−3:2)で精製し、生成物として旦を2,0m7(収
率88%)得た。
Ta. Remove the solvent with a vacuum pump and then remove it with toluene. The solvent was distilled off using silica gel (3 times), and silica gel Kasimuku L171~(M
Purification was performed using Ck silica gel (0.69:ethyl acetate:hexane (3:2)) to obtain 2.0 m7 (yield: 88%) of dandelion as a product.

IR(CIiCす3) : 3720−3240.17
/lo。
IR (CIiC3): 3720-3240.17
/lo.

1730cm−1 1」NMR(CDCu3.90M1−!z 、+n+m
 ) δ :0.89 (t、3. J −6,411
z 、CI−h ) 、1.1−2.1 (+n、 2
1. CI−+2 X9. CM、 alld ol−
1x2> 、2.32 (+、、2. J= 7.0H
z 、C112C00C) 、2.44 ((1,2,
J= 2.0+17 、Cl12 G=0) 、2.7
9 (dd、1 、J =11.6l−lz 。
1730cm-1 1'' NMR (CDCu3.90M1-!z, +n+m
) δ : 0.89 (t, 3. J −6,411
z, CI-h), 1.1-2.1 (+n, 2
1. CI-+2 X9. CM, alld ol-
1x2> , 2.32 (+, 2. J= 7.0H
z , C112C00C) , 2.44 ((1,2,
J=2.0+17, Cl12G=0), 2.7
9 (dd, 1, J = 11.6l-lz.

7.0Hz 、Cl−10=o) 、3.[i? (s
、3. 0CLl、3)、4.08 (br、Q、1.
 J = (i、21−12 、CNo)、4.51 
(m、1. Cll0>、5.37 (dd。
7.0Hz, Cl-10=o), 3. [i? (s
, 3. 0CLl, 3), 4.08 (br, Q, 1.
J = (i, 21-12, CNo), 4.51
(m, 1. Cll0>, 5.37 (dd.

1 、J =15.4. 7.ol−1z 、Vi++
y 1 ) 、5.63(dd、1 、J=1!i、4
. 6.2H2) :CNMR(CDCす3 、 90
M Ll z、1+1+m ) δ14.1. 22.
7. 24.8. 25,2. 26,9. 2B、0
. 29.0゜29.5. 31.8. 34.0. 
3G、9. 47.9. 48.2. !+1.!l。
1, J = 15.4. 7. ol-1z, Vi++
y 1 ), 5.63 (dd, 1 , J=1!i, 4
.. 6.2H2): CNMR (CDCS3, 90
M Ll z, 1+1+m ) δ14.1. 22.
7. 24.8. 25,2. 26,9. 2B, 0
.. 29.0°29.5. 31.8. 34.0.
3G, 9. 47.9. 48.2. ! +1. ! l.

54.9. (i8.1. 72.8. 12[3,G
、138.8. 174.4゜217.3 参考脅11 100dのナスラフラスコにアルゴン気流下、−78℃
で2.6− t−ブチル−4−メチルフー1ノールとジ
ネノープチルアルミウニムの当(nトルエン溶液0.I
AGヲ20.4adlヲ人h In l’l’ u T
おく、そこへdr■トルエン6dに溶かした12をステ
ンレスヂューブで加えた。311”7間かけて一20℃
に昇温したのら、=20°Cで25時間撹拌した。反応
液を酢酸エチル10dで希釈したのち、飽和酒石酸水素
すトリウム水溶液40dを加え、にり振とうした。有機
層、水層を分離しICのち、水層をn1酸エチルで抽出
した。
54.9. (i8.1.72.8.12[3,G
, 138.8. 174.4゜217.3 Reference 11 A 100 d eggplant flask was heated at -78℃ under an argon stream.
2.6-t-Butyl-4-methylfurinol and dinenobutylaluminium (n toluene solution 0.1
AGwo20.4adlwojinh In l'l' u T
12 dissolved in 6 d of dr. toluene was added thereto using a stainless steel tube. 311" - 20℃ for 7 minutes
After the temperature was raised to , it was stirred at =20°C for 25 hours. After diluting the reaction solution with 10 d of ethyl acetate, 40 d of saturated aqueous sodium hydrogen tartrate solution was added, followed by shaking. The organic layer and the aqueous layer were separated, and after IC, the aqueous layer was extracted with ethyl n1 acid.

(20dX2)。有機層を合わせ、無水硫酸ナトリウム
上で乾燥した。減圧濃縮後、シリカゲルカラムクロマト
グラフィーに供しくMOrckシリカゲル15g;酢エ
チ:へキチン:ベンゼン−1ニア:1→1:0:O)、
生成物とし′〔上を121#1g(収率I R(CII
CUs ) : 3GOO−3320,172’acm
−’11 NMR(CDCリ a 、9QM l−11
、1111111> 6 :0、(+4 (S、6. 
Si C113X2> 、0.7− 1.1<12. 
Si C(C113> 3 and C113) 、1
.1−2.7(if、31. ClI2 X14. C
I−IX 2. alld oil )、3,37 4
.3(Ill、8.OCI+3 、cHox3and 
C11z O) 、4.67 (II、1 、 0CI
IO) 。
(20dX2). The organic layers were combined and dried over anhydrous sodium sulfate. After concentration under reduced pressure, 15 g of MOrck silica gel was subjected to silica gel column chromatography;
The product was 121#1g (yield IR
CUs): 3GOO-3320,172'acm
-'11 NMR (CDCli a, 9QM l-11
, 1111111> 6 :0, (+4 (S, 6.
Si C113X2>, 0.7-1.1<12.
Si C (C113> 3 and C113), 1
.. 1-2.7(if, 31.ClI2X14.C
I-IX 2. alld oil), 3,37 4
.. 3(Ill, 8.OCI+3, cHox3and
C11z O) , 4.67 (II, 1, 0CI
IO).

!i、2− !i、G(m、2. vinyl )参考
例2 10〆の試験管にアルゴン気流士、−71iY; ’(
’谷11例1と同じ還元剤111Idlを入れ撹拌しく
’ aj<。そこへdry −1’ 01uelle2
 ad!に溶かし1.:13をステンレスブーユーブで
加えlζ。3時間か1)で−20℃に胃謁し/Sのら、
0.83威の還元剤を追加し、−20℃でさらに3時間
撹拌し、再び(1,83−加え、2時間30分撹拌した
。反応液を酢酸エチル51dlで希釈したのち、飽和酒
石酸水酸すトリウム溶液10−を加え、よく撹Ji L
、 /ζ。有機層、本図分離後、水層を酢酸エチルで2
回抽出した(2xlOIIdl)右1mを合わせ、無水
硫酸すトリウムで乾燥した。減圧rfA縮後、シリカゲ
ルカラムクロマ1−グラフィーに供し、(fvlcrc
kシリ)ノグル3び;酢エヂ:ヘユ1°ザン:ベンゼン
=1ニア:1)、生成物β−を26■(収率7G% )
 得Iこ。
! i,2-! i, G (m, 2. vinyl) Reference example 2 Place 10 test tubes in an argon stream, -71iY;
'Pour the same reducing agent 111Idl as in Example 1 and stir.'aj<. Dry there -1' 01uelle2
ad! Dissolve in 1. :Add 13 with a stainless steel tube. Heat to -20℃ for 3 hours or 1).
0.83% of reducing agent was added, and the mixture was further stirred at -20°C for 3 hours, and (1,83-) was added again and stirred for 2 hours and 30 minutes. After diluting the reaction solution with 51 dl of ethyl acetate, saturated tartaric acid solution Add thorium acid solution 10- and stir well.
, /ζ. After separating the organic layer, the aqueous layer was diluted with ethyl acetate.
The right 1 m of the extracts (2xlOIIdl) were combined and dried over anhydrous sodium sulfate. After reduced pressure rfA condensation, it was subjected to silica gel column chromatography, (fvlcrc
K sili) Nogle 3; Vinegar: Heyu 1° Zan: Benzene = 1 Ni: 1), product β-26μ (yield 7G%)
I got it.

このものの性質は@前例1のぞれど同じであった。The properties of this thing were the same in @Example 1.

Claims (1)

【特許請求の範囲】 1、 下記式(1) 式中R11は01〜C+oのアルキル基、又は1−り(
C1−07)炭化水素シリル基を表わし、R2、R3は
同一もしくは異なり水素原子、置換もしくは非置換のC
1〜C+aの)アルキル基又は置換もしくは非置換の5
〜6員のシクロアル4−ル葛を表わし、)(31はトリ
(C+〜C7)炭化水素シリル基を表わし、1マ引は水
酸拉の酸素原子と共に7セタ一ル結合を形成する基を表
わす。 で表わされるプロスタグランデインド1α類の9位の水
酸基を水酸基の酸素原子と共に7Lタ一ル結合を形成す
る基で保占し、下記式(力式中1又1111で2.1で
3.1(31,1(41はF記に同じで、(:’< l
はl<41ど1iil □−又は異なり水酸基の酸素原
子と共にアルタール結合を形成り“るりを表わり。 で表わされる保シされlこ/I’lスタグランン゛イン
F1α類を得、これを選択的脱保−W1次いで62化し
た後必要に応じて説保訛及σ/又は加水分解反式中R2
、R3は上記定義に同じ、1<1 は水糸1京子、(/
I〜CIOのアル−1,ル基を表わし、R” 、R6は
同一もしくは菫なり水系131を子又は水酸基の酸素原
子と共に7 ’tタール結合を形成する基を表わ′す。 で表わされるプロスタグラディンD1類の″M法2. 
選択的11;2保護反応をテ1ヘラー11−ブヂルアン
モニウムフルオリドを用いて行なう特許請求の範囲第1
項記載のプロスタグランγインD1類の製法 3、 酸化反応をクロム酸素酸化剤を用いて行なう特許
請求の範囲第1項又は第2項のいづれが1項記載のプロ
スタグラディンD1類の製法4、 上記式(1)におい
て、R11がメヂル基又は土デル基である特許′[請求
の屈IL11第11n〜第3項のいずれか1項記載のプ
ロスタグランγインD1類の新製進法。 5、 上記式(1)にJ3いて、R3が水素原子C8り
る特許請求の範囲第11Ei〜第4 Jljのいずれが
i Jji記載のプロスタグランディンD1類の新製進
法。 6、 上記式(1)において、R2が11−ペンデル基
、n−ヘクシル基、2−メヂルー1へクシ隻基、シクロ
ヘキシル基、又はシクロペンチル基である特許請求の範
囲第1項〜第5項のいずれか1項記載のプロスタグラン
ディンD1類の製法 7、 上記式(1)において1で31がトす■プルシリ
ル阜又はし−ブヂルジメヂルシリル阜である特に′l晶
求の範囲第i ]1〜第6]j4のいずれか1項記載の
プL1スタグランデインD+F、flの”12人8、 
上記式(2)にJ3いC11く引、1<51が同一しし
くは異なり2−テ1〜ラヒド1」ピラニルJJ¥、1−
11−キシエチル基、2−メ1−キシ−2−JL:lピ
ル基又は(2−メト4−シ]二1へ4−シ)メチ11遍
Jである特許請求の範囲第11丁1〜第7項のいずれか
1項記載の/目スタグラン)′インD+類の新興N ン
[Claims] 1. In the following formula (1), R11 is an alkyl group of 01 to C+o, or 1-(
C1-07) represents a hydrocarbon silyl group, R2 and R3 are the same or different hydrogen atoms, substituted or unsubstituted C
1 to C+a) alkyl group or substituted or unsubstituted 5
- represents a 6-membered cycloal-4-l group, ) (31 represents a tri(C+ to C7) hydrocarbon silyl group, and 1 represents a group that forms a 7-cetal bond with the oxygen atom of hydroxyl) The hydroxyl group at position 9 of the prostaglandin 1α group represented by is occupied by a group that forms a 7L bond with the oxygen atom of the hydroxyl group, and .1(31,1(41 is the same as in F, (:'< l
When l<41, 1iil □- or different from that, it forms an altar bond with the oxygen atom of the hydroxyl group and represents ``Ruri''. Debonding - W1 Then, after converting to 62, if necessary, change the explanation and σ / or R2 in the hydrolysis reaction formula
, R3 is the same as the above definition, 1<1 is Mizuito 1 Kyoko, (/
Represents an alkyl group of I to CIO, and R'' and R6 are the same or violet and represent a group that forms a 7't tar bond with an aqueous group 131 as a child or with an oxygen atom of a hydroxyl group. "M method 2. of prostaglandin D1 class.
Claim 1 wherein the selective 11;2 protection reaction is carried out using Te1haler 11-butylammonium fluoride.
3. Process 3 for producing prostagland γ-in D1 as described in Claim 4; Process 4 for producing prostagland D1 as described in Claim 1, in which the oxidation reaction is carried out using a chromium oxygen oxidizing agent. In the above formula (1), R11 is a del group or a del group. A new process for producing prostaglan gamma-in D1 according to any one of claims 11n to 3 of claim IL11. 5. In the above formula (1), J3 is a hydrogen atom C8, and any of Claims 11Ei to 4th Jlj is i. A new method for producing prostaglandin D1 class as described in Jji. 6. Claims 1 to 5, wherein in the above formula (1), R2 is a 11-pendel group, an n-hexyl group, a 2-medyl-1-hexyl group, a cyclohexyl group, or a cyclopentyl group. Process 7 for producing prostaglandin D1 according to any one of the above formulas (1), where 1 and 31 in the above formula (1) are pulsylsilyl or butyldimedylsilyl, especially the crystallization range i ]1 to 6]P L1 staglandin D+F, fl's "12 people 8," according to any one of j4.
In the above formula (2), J3 is subtracted by C11, and 1<51 is the same or different.
11-xyethyl group, 2-me1-xy-2-JL:l pyl group or (2-meth4-cy]21he4-cy)methy11J Emerging N people of category D+ listed in any one of Section 7
JP58187132A 1983-10-07 1983-10-07 Production of prostaglandin d1 Granted JPS6078962A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP58187132A JPS6078962A (en) 1983-10-07 1983-10-07 Production of prostaglandin d1

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58187132A JPS6078962A (en) 1983-10-07 1983-10-07 Production of prostaglandin d1

Publications (2)

Publication Number Publication Date
JPS6078962A true JPS6078962A (en) 1985-05-04
JPH0210151B2 JPH0210151B2 (en) 1990-03-06

Family

ID=16200680

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58187132A Granted JPS6078962A (en) 1983-10-07 1983-10-07 Production of prostaglandin d1

Country Status (1)

Country Link
JP (1) JPS6078962A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3663228B1 (en) 2018-07-12 2023-09-06 Kao Corporation Sheet material container

Also Published As

Publication number Publication date
JPH0210151B2 (en) 1990-03-06

Similar Documents

Publication Publication Date Title
JPH07504664A (en) Halichondrins and related compounds
Jung et al. Additional bioactive heptenes from Melodorum fruticosum
WO1995010266A1 (en) Nitrogen monoxide synthesis inhibitor
JPS6078962A (en) Production of prostaglandin d1
JPH07508501A (en) Fluorine-containing vitamin D↓3 analogue
JPS58201735A (en) Preparation of polyprenyl compound or mixture thereof
Hatanaka et al. Reactions of 3-[(trimethylsilyl) methyl]-2-cyclohexen-1-one with carbonyl compounds. Regio-and chemoselective condensations
US4868204A (en) Mycalamide compounds, compositions thereof and methods of preparation and use
Molnár et al. Studies on the Conversions of Diols and Cyclic Ethers. Part 48. Dehydration of alcohols and diols on the action of dimethylsulfoxide
JPS61275266A (en) Retinoid derivative
JP2512400B2 (en) Methyl-4,6-0- [3- (1-methylcyclohexen-4-yl) butylidene] -D-glycoside
CN115181013B (en) Preparation method and application of key intermediate of modified fatty acid type PET reagent precursor
JPS58216178A (en) 5,6-epoxidized vitamin d3 derivative
JPS6231700B2 (en)
JPS625402B2 (en)
JP2609145B2 (en) Aliphatic ketones and aliphatic alcohols
JP2512401B2 (en) Methyl-4,6-0- (7-hydroxy-3,7-dimethyl) octylidene-D-glycoside
JPH08245612A (en) Production of 2-deoxy-2,2-difluoro-beta-d-libopentopyranose
CH676598A5 (en)
JPH03130291A (en) Periplanone b analogue, its preparation and intermediate thereof, and cockroach-attracting agent
JPH01193288A (en) Unsaturated alycyclic ester of macrolide and lincosamide antibiotics, production thereof and drug/cosmetics
JPH0359058B2 (en)
JP2743121B2 (en) Nitric oxide synthesis inhibitor
JPH0321034B2 (en)
JPS62209092A (en) Lactose higher fatty acid derivative